SC 13G Filing

Company

Stoke Therapeutics, Inc.

Filed

July 1, 2019

Accession Number

0000929638-19-000658

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →